Evidence map›Paper›PMID 40862233›Full record

ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2025

Exosomes in Diabetic Wound Healing: Mechanisms, Applications, and Perspectives.

Jialian Yi, Qisheng Tang, Shuifen Sun, Hongqing Xie, Linping Wang, Xin Yin

Abstract readReview
In one paragraph

Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. [Experimental investigation of skin tissue-derived extracellular vesicles isolated from type 2 diabetic foot ulcers in impaired wound healing].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jialian YiThe Regenerative Medicine Research Center, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, People's Republic of China.ORCID 0009-0001-8193-7203
Qisheng TangThe Regenerative Medicine Research Center, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, People's Republic of China.
Shuifen SunThe Regenerative Medicine Research Center, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, People's Republic of China.
Hongqing XieThe Regenerative Medicine Research Center, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, People's Republic of China.
Linping WangThe Regenerative Medicine Research Center, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, People's Republic of China.
Xin YinThe Regenerative Medicine Research Center, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Delayed wound healing is a major complication of diabetes, significantly impacting patients' quality of life. Traditional treatments, such as wound debridement, dressing application, and growth factor therapy, often suffer from limited efficacy and significant side effects. In recent years, exosomes have emerged as a promising therapeutic strategy for promoting diabetic skin wound healing. Exosomes, nano-sized vesicles secreted by cells, are rich in bioactive components, including proteins, nucleic acids, and lipids, enabling them to participate in intercellular communication and modulate cellular functions. Studies have demonstrated that exosomes derived from stem cells can significantly enhance diabetic wound healing. This effect is attributed to their ability to modulate key wound healing processes, including shortening the inflammatory phase, promoting angiogenesis, facilitating cell migration and re-epithelialization, and regulating collagen remodeling. Moreover, various pre-treatment strategies, applied to either the exosome-secreting cells or the isolated exosomes themselves, can significantly augment their therapeutic efficacy. As natural nanocarriers with low immunogenicity and high targeting specificity, exosomes hold great promise in tissue repair and regenerative medicine. This review summarizes the latest research progress on exosomes in diabetic wound healing, exploring their mechanisms of action and potential clinical applications, thereby establishing a foundation for the clinical translation of exosomes in diabetic wound management.

Indexed as

angiogenesisbiomaterialsdiabetesengineered exosomesexosomeswound healing

Identifiers

PMID40862233
PMCPMC12377389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.